The Netherlands, June 17, 2025 — The Avishield portfolio currently consists of eight products manufactured, marketed and sold by Dechra into 29 countries. In addition, the Dechra poultry vaccine research and development (R&D) team of 24 people based in Zagreb, Croatia, and corresponding pipeline of potential future products, will also transfer to Vaxxinova upon completion, allowing them to continue their work towards commercialisation.

Read the full press release